Annual Accounts Payable:
$16.59M+$1.80M(+12.15%)Summary
- As of today, CPRX annual accounts payable is $16.59 million, with the most recent change of +$1.80 million (+12.15%) on December 31, 2024.
 - During the last 3 years, CPRX annual accounts payable has risen by +$13.82 million (+499.46%).
 - CPRX annual accounts payable is now at all-time high.
 
Performance
CPRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$5.53M-$5.67M(-50.63%)Summary
- As of today, CPRX quarterly accounts payable is $5.53 million, with the most recent change of -$5.67 million (-50.63%) on June 30, 2025.
 - Over the past year, CPRX quarterly accounts payable has dropped by -$1.59 million (-22.32%).
 - CPRX quarterly accounts payable is now -66.68% below its all-time high of $16.59 million, reached on December 31, 2024.
 
Performance
CPRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CPRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | 
|---|---|---|
| 1Y1 Year | +12.2% | -22.3% | 
| 3Y3 Years | +499.5% | +138.8% | 
| 5Y5 Years | +303.0% | -4.8% | 
CPRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +499.5% | -66.7% | +118.6% | 
| 5Y | 5-Year | at high | +499.5% | -66.7% | +175.7% | 
| All-Time | All-Time | at high | >+9999.0% | -66.7% | >+9999.0% | 
CPRX Accounts Payable History
| Date | Annual | Quarterly | 
|---|---|---|
| Jun 2025 | -  | $5.53M(-50.6%)  | 
| Mar 2025 | -  | $11.20M(-32.5%)  | 
| Dec 2024 | $16.59M(+12.2%)  | $16.59M(+43.5%)  | 
| Sep 2024 | -  | $11.56M(+62.5%)  | 
| Jun 2024 | -  | $7.12M(-30.7%)  | 
| Mar 2024 | -  | $10.26M(-30.6%)  | 
| Dec 2023 | $14.79M(+272.2%)  | $14.79M(+221.8%)  | 
| Sep 2023 | -  | $4.60M(+4.0%)  | 
| Jun 2023 | -  | $4.42M(+30.4%)  | 
| Mar 2023 | -  | $3.39M(-14.7%)  | 
| Dec 2022 | $3.98M(+43.6%)  | $3.98M(+57.2%)  | 
| Sep 2022 | -  | $2.53M(+9.2%)  | 
| Jun 2022 | -  | $2.31M(-55.0%)  | 
| Mar 2022 | -  | $5.14M(+85.7%)  | 
| Dec 2021 | $2.77M(-35.0%)  | $2.77M(+0.6%)  | 
| Sep 2021 | -  | $2.75M(-5.9%)  | 
| Jun 2021 | -  | $2.92M(+14.2%)  | 
| Mar 2021 | -  | $2.56M(-39.8%)  | 
| Dec 2020 | $4.26M(+3.4%)  | $4.26M(+112.2%)  | 
| Sep 2020 | -  | $2.01M(-65.5%)  | 
| Jun 2020 | -  | $5.80M(+330.8%)  | 
| Mar 2020 | -  | $1.35M(-67.3%)  | 
| Dec 2019 | $4.12M(+76.2%)  | $4.12M(-0.7%)  | 
| Sep 2019 | -  | $4.15M(+24.6%)  | 
| Jun 2019 | -  | $3.33M(+13.2%)  | 
| Mar 2019 | -  | $2.94M(+25.8%)  | 
| Dec 2018 | $2.34M(>+9900.0%)  | $2.34M(+74.3%)  | 
| Sep 2018 | -  | $1.34M(+45.4%)  | 
| Jun 2018 | -  | $922.60K(>+9900.0%)  | 
| Mar 2018 | -  | $0.00(0.0%)  | 
| Dec 2017 | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2017 | -  | $0.00(0.0%)  | 
| Jun 2017 | -  | $0.00(0.0%)  | 
| Mar 2017 | -  | $0.00(0.0%)  | 
| Dec 2016 | $0.00(0.0%)  | $0.00(0.0%)  | 
| Sep 2016 | -  | $0.00(0.0%)  | 
| Jun 2016 | -  | $0.00(0.0%)  | 
| Mar 2016 | -  | $0.00(0.0%)  | 
| Dec 2015 | $0.00  | $0.00(0.0%)  | 
| Date | Annual | Quarterly | 
|---|---|---|
| Sep 2015 | -  | $0.00(0.0%)  | 
| Jun 2015 | -  | $0.00(0.0%)  | 
| Mar 2015 | -  | $0.00(0.0%)  | 
| Dec 2014 | $0.00(-100.0%)  | $0.00(0.0%)  | 
| Sep 2014 | -  | $0.00(0.0%)  | 
| Jun 2014 | -  | $0.00(-100.0%)  | 
| Mar 2014 | -  | $932.10K(+9.6%)  | 
| Dec 2013 | $850.80K(-37.7%)  | $850.80K(-42.3%)  | 
| Sep 2013 | -  | $1.47M(+228.6%)  | 
| Jun 2013 | -  | $448.30K(-21.0%)  | 
| Mar 2013 | -  | $567.20K(-58.5%)  | 
| Dec 2012 | $1.37M(+417.5%)  | $1.37M(+283.7%)  | 
| Sep 2012 | -  | $355.90K(+59.6%)  | 
| Jun 2012 | -  | $223.00K(-36.3%)  | 
| Mar 2012 | -  | $350.30K(+32.7%)  | 
| Dec 2011 | $263.90K(+149.2%)  | $263.90K(+51.7%)  | 
| Sep 2011 | -  | $174.00K(-63.6%)  | 
| Jun 2011 | -  | $478.00K(+12.4%)  | 
| Mar 2011 | -  | $425.40K(+301.7%)  | 
| Dec 2010 | $105.90K(-57.6%)  | $105.90K(-56.1%)  | 
| Sep 2010 | -  | $241.30K(-4.2%)  | 
| Jun 2010 | -  | $252.00K(+185.4%)  | 
| Mar 2010 | -  | $88.30K(-64.6%)  | 
| Dec 2009 | $249.60K(-25.0%)  | $249.60K(+53.0%)  | 
| Sep 2009 | -  | $163.10K(-40.8%)  | 
| Jun 2009 | -  | $275.70K(-62.6%)  | 
| Mar 2009 | -  | $737.60K(+121.7%)  | 
| Dec 2008 | $332.70K(+51.3%)  | $332.70K(-47.7%)  | 
| Sep 2008 | -  | $635.60K(+250.6%)  | 
| Jun 2008 | -  | $181.30K(-42.7%)  | 
| Mar 2008 | -  | $316.60K(+44.0%)  | 
| Dec 2007 | $219.90K(-50.9%)  | $219.90K(-4.2%)  | 
| Sep 2007 | -  | $229.50K(+56.8%)  | 
| Jun 2007 | -  | $146.40K(-53.2%)  | 
| Mar 2007 | -  | $312.50K(-30.3%)  | 
| Dec 2006 | $448.10K(+560.9%)  | $448.10K(+7.3%)  | 
| Sep 2006 | -  | $417.80K(+1577.9%)  | 
| Jun 2006 | -  | $24.90K(-63.3%)  | 
| Dec 2005 | $67.80K(+120.8%)  | $67.80K(+120.8%)  | 
| Dec 2004 | $30.70K  | $30.70K  | 
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual accounts payable?
 - What is the all-time high annual accounts payable for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. annual accounts payable year-on-year change?
 - What is Catalyst Pharmaceuticals, Inc. quarterly accounts payable?
 - What is the all-time high quarterly accounts payable for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
 
What is Catalyst Pharmaceuticals, Inc. annual accounts payable?
The current annual accounts payable of CPRX is $16.59M
What is the all-time high annual accounts payable for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual accounts payable is $16.59M
What is Catalyst Pharmaceuticals, Inc. annual accounts payable year-on-year change?
Over the past year, CPRX annual accounts payable has changed by +$1.80M (+12.15%)
What is Catalyst Pharmaceuticals, Inc. quarterly accounts payable?
The current quarterly accounts payable of CPRX is $5.53M
What is the all-time high quarterly accounts payable for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly accounts payable is $16.59M
What is Catalyst Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
Over the past year, CPRX quarterly accounts payable has changed by -$1.59M (-22.32%)